https://doi.org/10.4081/ecj.2024.12225
Outcomes of bailout use of continuous positive airway pressure in patients with severe COVID-19 respiratory failure
Submitted: 23 December 2023
Accepted: 7 March 2024
Published: 8 April 2024
Accepted: 7 March 2024
Abstract Views: 3164
PDF: 215
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
During the first wave of the Coronavirus-19 (COVID-19) pandemic, due to an overflow of patients in the ICU, continuous positive airway pressure (CPAP) was used as a last resort to mechanical ventilation. The purpose of this study is to evaluate prognostic factors in COVID-19 severe respiratory failure patients treated with helmet CPAP. We reviewed the medical records of COVID-19 respiratory failure patients treated with H-CPAP at the Emergency Department from February 23rd to March 14th, 2020. A total of 202 (40%) patients admitted for respiratory failure due to COVID-19 pneumonia were considered. 129 (64%) patients received H-CPAP, while 73 (36%) required endotracheal intubation and invasive mechanical ventilation despite initial H-CPAP. 99 patients (49%) died. The mortality rate in the IMV group was 37%, compared to 56% in the group that received only H-CPAP (p= 0.004). The age and comorbidities of patients in the two groups differed significantly (p < 0.001). Age and PaO2/FiO2 were identified as the only independent risk factors for death. Identifying these independent predictors of mortality in patients with acute respiratory insufficiency may help clinicians optimize treatment escalation.
Brusasco C, Corradi F, Di Domenico A, et al. CPAP-Covid-19 study group; collaborators of the Galliera CPAP-COVID-19 study group are. Continuous positive airway pressure in COVID-19 patients with moderate-to-severe respiratory failure. Eur Respir J 2021;57:2002524.
DOI: https://doi.org/10.1183/13993003.02524-2020
Duca A, Memaj I, Zanardi F, et al. Severity of respiratory failure and outcome of patients needing a ventilatory support in the Emergency Department during Italian novel coronavirus SARS-CoV2 outbreak: Preliminary data on the role of Helmet CPAP and Non-Invasive Positive Pressure Ventilation. EClinicalMedicine 2020;24:100419.
DOI: https://doi.org/10.1016/j.eclinm.2020.100419
Oranger M, Gonzalez-Bermejo J, Dacosta-Noble P, et al. Continuous positive airway pressure to avoid intubation in SARS-CoV-2 pneumonia: a two-period retrospective case-control study. Eur Respir J 2020;56:2001692.
DOI: https://doi.org/10.1183/13993003.01692-2020
Grasselli G, Greco M, Zanella A, et al. Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy. JAMA Intern Med 2020;180:1345-55. Erratum in: JAMA Intern Med 2021;181:1021.
Alhazzani W, Møller MH, Arabi YM, et al. Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19). Intensive Care Med 2020;46:854-87.
DOI: https://doi.org/10.1007/s00134-020-06022-5
Rali AS, Howard C, Miller R, et al. Helmet CPAP revisited in COVID-19 pneumonia: A case series. Can J Respir Ther 2020;56:32-4.
DOI: https://doi.org/10.29390/cjrt-2020-019
Lucchini A, Giani M, Isgrò S, et al. The "helmet bundle" in COVID-19 patients undergoing non invasive ventilation. Intensive Crit Care Nurs 2020;58:102859.
DOI: https://doi.org/10.1016/j.iccn.2020.102859
Grieco DL, Menga LS, Cesarano M, et al. Effect of Helmet Noninvasive Ventilation vs High-Flow Nasal Oxygen on Days Free of Respiratory Support in Patients With COVID-19 and Moderate to Severe Hypoxemic Respiratory Failure: The HENIVOT Randomized Clinical Trial. JAMA 2021;325:1731-43.
DOI: https://doi.org/10.1001/jama.2021.4682
Amirfarzan H, Cereda M, Gaulton TG, et al. Use of Helmet CPAP in COVID-19 - A practical review. Pulmonology 2021;27:413-22.
DOI: https://doi.org/10.1016/j.pulmoe.2021.01.008
Rauseo M, Mirabella L, Caporusso RR, et al. SARS-CoV-2 pneumonia succesfully treated with cpap and cycles of tripod position: a case report. BMC Anesthesiol 2021;21:9.
DOI: https://doi.org/10.1186/s12871-020-01221-5
Ing RJ, Bills C, Merritt G, et al. Role of Helmet-Delivered Noninvasive Pressure Support Ventilation in COVID-19 Patients. J Cardiothorac Vasc Anesth 2020;34:2575-9.
DOI: https://doi.org/10.1053/j.jvca.2020.04.060
Kofod LM, Nielsen Jeschke K, Kristensen MT, et al. COVID-19 and acute respiratory failure treated with CPAP. Eur Clin Respir J 2021;8:1910191.
DOI: https://doi.org/10.1080/20018525.2021.1910191
Ramirez GA, Bozzolo EP, Gobbi A, et al. Outcomes of noninvasive ventilation as the ceiling of treatment in patients with COVID-19. Panminerva Med 2022;64:506-16.
DOI: https://doi.org/10.23736/S0031-0808.21.04280-4
Menzella F, Barbieri C, Fontana M, et al. Effectiveness of noninvasive ventilation in COVID-19 related-acute respiratory distress syndrome. Clin Respir J 2021;15:779-87.
DOI: https://doi.org/10.1111/crj.13361
De Vita N, Scotti L, Cammarota G, et al. Predictors of intubation in COVID-19 patients treated with out-of-ICU continuous positive airway pressure. Pulmonology 2022;28:173-80.
DOI: https://doi.org/10.1016/j.pulmoe.2020.12.010
Perkins GD, Couper K, Connolly B, et al. RECOVERY-Respiratory Support: respiratory strategies for patients with suspected or proven COVID-19 respiratory failure; continuous positive airway pressure, high-flow nasal oxygen, and standard care: a structured summary of a study protocol for a randomised controlled trial. Trials 2020;21:687.
DOI: https://doi.org/10.1186/s13063-020-04617-3
Cosentini R, Brambilla AM, Aliberti S, et al. Helmet continuous positive airway pressure vs oxygen therapy to improve oxygenation in community-acquired pneumonia: a randomized, controlled trial. Chest 2010;138:114-20.
DOI: https://doi.org/10.1378/chest.09-2290
Bellani G, Patroniti N, Greco M, et al. The use of helmets to deliver non-invasive continuous positive airway pressure in hypoxemic acute respiratory failure. Minerva Anestesiol 2008;74:651-6.
Brambilla AM, Aliberti S, Prina E, et al. Helmet CPAP vs. oxygen therapy in severe hypoxemic respiratory failure due to pneumonia. Intensive Care Med 2014;40:942-9.
DOI: https://doi.org/10.1007/s00134-014-3325-5
Gattinoni L, Chiumello D, Caironi P, et al. COVID-19 pneumonia: different respiratory treatments for different phenotypes? Intensive Care Med 2020;46:1099-102.
DOI: https://doi.org/10.1007/s00134-020-06033-2
Cammarota G, Esposito T, Azzolina D, et al. Noninvasive respiratory support outside the intensive care unit for acute respiratory failure related to coronavirus-19 disease: a systematic review and meta-analysis. Crit Care 2021;25:268.
DOI: https://doi.org/10.1186/s13054-021-03697-0
Daugherty Biddison EL, Faden R, Gwon HS, et al. Too Many Patients…A Framework to Guide Statewide Allocation of Scarce Mechanical Ventilation During Disasters. Chest 2019;155:848-54.
DOI: https://doi.org/10.1016/j.chest.2018.09.025
Coppadoro A, Benini A, Fruscio R, et al. Helmet CPAP to treat hypoxic pneumonia outside the ICU: an observational study during the COVID-19 outbreak. Crit Care 2021;25:80.
DOI: https://doi.org/10.1186/s13054-021-03502-y
How to Cite
Giannone, A., Piazza, I., Preti, C., Pisano, E., Ghirardi, A., Benetti, A., Fagiuoli, S., Lorini, F. L., Rizzi, M., Di Marco, F., & Cosentini, R. (2024). Outcomes of bailout use of continuous positive airway pressure in patients with severe COVID-19 respiratory failure. Emergency Care Journal, 20(2). https://doi.org/10.4081/ecj.2024.12225
Copyright (c) 2024 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
